OTLK SEC Filings | SEC Document SEARCH
Back to Search
Outlook Therapeutics, Inc. (OTLK)
Ticker: OTLK
CIK: 0001649989
56
Filings Found (Last 1 Year)
Filter Filings
All
8-K
2026. 9. 25.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 9. 16.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 9. 1.
Lundquist Kevin Michael (CIK 0002074701)
Insider trading report
Open Filing
8-K
2026. 8. 23.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
10-Q
2026. 6. 30.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Quarterly report
10-Q
Open Filing
4
2026. 8. 14.
KENYON LAWRENCE A (CIK 0001230484)
Insider trading report
PRIMARY DOCUMENT
Open Filing
4
2026. 8. 14.
Jahr Robert Charles (CIK 0002076177)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
8-K
2026. 8. 12.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
424B5
2026. 8. 14.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 8. 14.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 8. 12.
Sukhtian Ghiath M. (CIK 0001717441)
Insider trading report
FORM 4
Open Filing
424B5
2026. 8. 12.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 8. 12.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 7. 29.
Sukhtian Faisal Ghiath (CIK 0001716033)
Insider trading report
PRIMARY DOCUMENT
Open Filing
8-K
2026. 7. 24.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 7. 21.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 7. 21.
KENYON LAWRENCE A (CIK 0001230484)
Insider trading report
PRIMARY DOCUMENT
Open Filing
4
2026. 7. 21.
Jahr Robert Charles (CIK 0002076177)
Insider trading report
PRIMARY DOCUMENT
Open Filing
8-K
2026. 7. 16.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 6. 26.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 6. 16.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 6. 2.
Haddadin Yezan Munther (CIK 0001718004)
Insider trading report
PRIMARY DOCUMENT
Open Filing
8-K
2026. 6. 1.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 5. 28.
Sukhtian Ghiath M. (CIK 0001717441)
Insider trading report
Open Filing
8-K
2026. 5. 29.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
424B5
2026. 5. 29.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 5. 28.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
4
2026. 5. 27.
Sukhtian Faisal Ghiath (CIK 0001716033)
Insider trading report
PRIMARY DOCUMENT
Open Filing
4
2026. 5. 26.
Haddadin Yezan Munther (CIK 0001718004)
Insider trading report
PRIMARY DOCUMENT
Open Filing
4
2026. 5. 26.
THURMAN RANDY H (CIK 0001204059)
Insider trading report
PRIMARY DOCUMENT
Open Filing
4
2026. 5. 26.
HILZINGER KURT J (CIK 0001191504)
Insider trading report
PRIMARY DOCUMENT
Open Filing
8-K
2026. 5. 26.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 5. 15.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
10-Q
2026. 3. 31.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Quarterly report
10-Q
Open Filing
424B5
2026. 5. 13.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 5. 12.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 4. 22.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
424B5
2026. 4. 23.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 4. 21.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 4. 7.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 3. 23.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
424B5
2026. 3. 25.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
424B5
2026. 3. 23.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Prospectus
424B5
Open Filing
8-K
2026. 3. 13.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 3. 6.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 3. 10.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 3. 5.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 2. 18.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
10-Q
2025. 12. 31.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Quarterly report
10-Q
Open Filing
8-K
2026. 2. 17.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2026. 2. 11.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2025. 12. 31.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
10-K
2025. 9. 30.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Annual report
10-K
Open Filing
8-K
2025. 12. 19.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2025. 11. 13.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
8-K
2025. 11. 3.
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Current report
FORM 8-K
Open Filing
Previous
Page 2 of 3
Next
